Global Viral Vaccines Market Insights, Forecast to 2025

Table of Contents

1 Viral Vaccines Market Overview

• 1.1 Product Overview and Scope of Viral Vaccines
• 1.2 Viral Vaccines Segment by Type
  • 1.2.1 Global Viral Vaccines Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Attenuated Vaccine
  • 1.2.3 Inactivated Vaccine
• 1.3 Viral Vaccines Segment by Application
  • 1.3.1 Viral Vaccines Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Pharmaceutical Factory
  • 1.3.4 Research Institute
  • 1.3.5 Others
• 1.4 Global Viral Vaccines Market Size Estimates and Forecasts
  • 1.4.1 Global Viral Vaccines Revenue 2015-2026
  • 1.4.2 Global Viral Vaccines Sales 2015-2026
  • 1.4.3 Viral Vaccines Market Size by Region: 2020 Versus 2026

2 Global Viral Vaccines Market Competition by Manufacturers

• 2.1 Global Viral Vaccines Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Viral Vaccines Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Viral Vaccines Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Viral Vaccines Manufacturing Sites, Area Served, Product Type
• 2.5 Viral Vaccines Market Competitive Situation and Trends
  • 2.5.1 Viral Vaccines Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Viral Vaccines Players (Opinion Leaders)

3 Viral Vaccines Retrospective Market Scenario by Region

• 3.1 Global Viral Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Viral Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Viral Vaccines Market Facts & Figures by Country
  • 3.3.1 North America Viral Vaccines Sales by Country
  • 3.3.2 North America Viral Vaccines Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Viral Vaccines Market Facts & Figures by Country
  • 3.4.1 Europe Viral Vaccines Sales by Country
  • 3.4.2 Europe Viral Vaccines Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Viral Vaccines Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Viral Vaccines Sales by Region
  • 3.5.2 Asia Pacific Viral Vaccines Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Viral Vaccines Market Facts & Figures by Country
  • 3.6.1 Latin America Viral Vaccines Sales by Country
  • 3.6.2 Latin America Viral Vaccines Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Viral Vaccines Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Viral Vaccines Sales by Country
  • 3.7.2 Middle East and Africa Viral Vaccines Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Viral Vaccines Historic Market Analysis by Type

• 4.1 Global Viral Vaccines Sales Market Share by Type (2015-2020)
• 4.2 Global Viral Vaccines Revenue Market Share by Type (2015-2020)
• 4.3 Global Viral Vaccines Price Market Share by Type (2015-2020)
• 4.4 Global Viral Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Viral Vaccines Historic Market Analysis by Application

• 5.1 Global Viral Vaccines Sales Market Share by Application (2015-2020)
• 5.2 Global Viral Vaccines Revenue Market Share by Application (2015-2020)
• 5.3 Global Viral Vaccines Price by Application (2015-2020)

6 Company Profiles and Key Figures in Viral Vaccines Business

• 6.1 GSK
  • 6.1.1 Corporation Information
  • 6.1.2 GSK Description, Business Overview and Total Revenue
  • 6.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 GSK Products Offered
  • 6.1.5 GSK Recent Development
• 6.2 Merck
  • 6.2.1 Merck Viral Vaccines Production Sites and Area Served
  • 6.2.2 Merck Description, Business Overview and Total Revenue
  • 6.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Merck Products Offered
  • 6.2.5 Merck Recent Development
• 6.3 Novartis
  • 6.3.1 Novartis Viral Vaccines Production Sites and Area Served
  • 6.3.2 Novartis Description, Business Overview and Total Revenue
  • 6.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Novartis Products Offered
  • 6.3.5 Novartis Recent Development
• 6.4 Pfizer
  • 6.4.1 Pfizer Viral Vaccines Production Sites and Area Served
  • 6.4.2 Pfizer Description, Business Overview and Total Revenue
  • 6.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Pfizer Products Offered
  • 6.4.5 Pfizer Recent Development
• 6.5 Sanofi
  • 6.5.1 Sanofi Viral Vaccines Production Sites and Area Served
  • 6.5.2 Sanofi Description, Business Overview and Total Revenue
  • 6.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Sanofi Products Offered
  • 6.5.5 Sanofi Recent Development
• 6.6 Bayer
  • 6.6.1 Bayer Viral Vaccines Production Sites and Area Served
  • 6.6.2 Bayer Description, Business Overview and Total Revenue
  • 6.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Bayer Products Offered
  • 6.6.5 Bayer Recent Development
• 6.7 Zoetis
  • 6.6.1 Zoetis Viral Vaccines Production Sites and Area Served
  • 6.6.2 Zoetis Description, Business Overview and Total Revenue
  • 6.6.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Zoetis Products Offered
  • 6.7.5 Zoetis Recent Development
• 6.8 AstraZeneca
  • 6.8.1 AstraZeneca Viral Vaccines Production Sites and Area Served
  • 6.8.2 AstraZeneca Description, Business Overview and Total Revenue
  • 6.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 AstraZeneca Products Offered
  • 6.8.5 AstraZeneca Recent Development
• 6.9 Johnson
  • 6.9.1 Johnson Viral Vaccines Production Sites and Area Served
  • 6.9.2 Johnson Description, Business Overview and Total Revenue
  • 6.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Johnson Products Offered
  • 6.9.5 Johnson Recent Development
• 6.10 CSL
  • 6.10.1 CSL Viral Vaccines Production Sites and Area Served
  • 6.10.2 CSL Description, Business Overview and Total Revenue
  • 6.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 CSL Products Offered
  • 6.10.5 CSL Recent Development

7 Viral Vaccines Manufacturing Cost Analysis

• 7.1 Viral Vaccines Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Viral Vaccines
• 7.4 Viral Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Viral Vaccines Distributors List
• 8.3 Viral Vaccines Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Viral Vaccines Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Viral Vaccines by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Viral Vaccines by Type (2021-2026)
• 10.2 Viral Vaccines Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Viral Vaccines by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Viral Vaccines by Application (2021-2026)
• 10.3 Viral Vaccines Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Viral Vaccines by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Viral Vaccines by Region (2021-2026)
• 10.4 North America Viral Vaccines Estimates and Projections (2021-2026)
• 10.5 Europe Viral Vaccines Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Viral Vaccines Estimates and Projections (2021-2026)
• 10.7 Latin America Viral Vaccines Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Viral Vaccines Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List